PD-L1
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
PD-L1
May 12, 2024, 16:18 |
Insight
Patrick Hwu: Insights into CAR design and optimal coupling to inhibit the PD-L1/PD-1 axis
Patrick Hwu shared on X/Twitter: "Science Saturday T-cells gene-modified with chimeric antigen receptors (CAR) can be…
May 10, 2024, 14:58 |
Blog
Lauren Brown: Another insightful article out of the AURORA collaboration
Lauren Brown, PhD Candidate at Westmead Institute for Medical Research, University of Sydney & Medical…
May 6, 2024, 19:10 |
Blog
Erman Akkus: ASCO Ed book on mNSCLC without oncogenic alterations
Erman Akkus, medical oncologist at Ankara Medical University, shared on Twitter/X: "Metastatic NSCLC without oncogenic…
May 2, 2024, 12:56 |
Blog
Susanna F. Greer: An unexpected GOOD sign - tumor associated macrophages and breast cancer
Susanna F. Greer, Chief Scientific Officer at the V Foundation, published the following newsletter on…
Apr 26, 2024, 10:00 |
Insight
Biagio Ricciuti: Our work on long-term outcomes to PD-1 monotherapy by increasing PD-L1 levels in NSCLC is out in JTO and JTO CRR
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, shared on X/Twitter: ''Our work on long-term…
Apr 22, 2024, 18:48 |
Insight
Piotr Wysocki: Single-agent immunotherapy is a wise choice as first-line treatment in elderly, advanced NSCLC patients, irrespectively of PD-L1 expression
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 18, 2024, 10:39 |
Insight
Arya Roy: Such an interesting finding! PD-L1 positivity varies by metastatic location in mTNBC!
Arya Roy, Hematology-Oncology Fellow at the Roswell Park Comprehensive Cancer Center, shared a post by…
Dec 23, 2023, 03:55 |
Blog
Shilpa Gupta: Our work on plat-ineligibility in Metastatic Urothelial Carcinoma and survival outcomes out in the Journal of the JNCI
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X/Twitter: "Our…
Sep 24, 2023, 18:03 |
Blog
Pashtoon Murtaza Kasi: The imagery at RareCyte Incorporated will blow your mind.
Quoting Pashtoon Murtaza Kasi, Oncologist and Researcher at Weill Cornel Medicine and New York- Presbyterian…
All:
9
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube